Emergent BioSolutions continues driving progress against opioid epidemic

In recognition of National Naloxone Awareness Day, Emergent BioSolutions is highlighting its ongoing efforts to combat the opioid epidemic in the U.S., including topline results from its new general population awareness survey on consumers’ understanding of opioid-related accidental overdose and fentanyl. The results show that there is a high level of awareness that fentanyl is an opioid, and that naloxone can reverse opioid overdoses, including those caused by fentanyl. It also found that there are still gaps in certain age groups and populations in understanding the role of naloxone in reversing opioid overdoses related to fentanyl. “Combating the opioid crisis takes a holistic approach across sectors, and Emergent is committed to raise awareness, increase access and availability of over-the-counter NARCAN Nasal Spray making it possible for anyone to save a life,” said Paul Williams, senior vice president, products head at Emergent. “National Naloxone Awareness Day commemorates Victoria Siegel’s tragic death from accidental overdose on June 6, 2015, as well as all lives lost from overdose, while heightening awareness and expanding access to life-saving naloxone, the standard of care for opioid overdose reversal.”